India may take WTO action against EU over drug clinical trials, says GVK
India may go to WTO if the European Union does not reconsider its decision to suspend the sale of about 700 generic drugs that were approved based on clinical trials by GVK Biosciences, the firm said.
Mumbai Last Updated: April 15, 2015 | 13:51 IST
The European Medicines Agency (EMA) suspension became effective in January, a month after France, Germany, Belgium and Luxembourg suspended the sale of 25 generic drugs that were approved based on trials conducted by GVK Biosciences. (Photo: Reuters)